Propel Bio Management »

Miragen Therapeutics shares owned by Propel Bio Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.9M 90k 21.58

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Ltd Partnr Int A (PAGP)
Achieve Life Sciences (ACHV)
Akero Therapeutics (AKRO)
Milestone Pharmaceuticals (MIST)
Applied Therapeutics (APLT)
Phathom Pharmaceuticals (PHAT)
Abeona Therapeutics Com New (ABEO)
Delcath Systems Com New (DCTH)
Celldex Therapeutics Com New (CLDX)
Tscan Therapeutics (TCRX)
Compass Pathways Sponsored Ads (CMPS)
Nektar Therapeutics Com New (NKTR)
Jasper Therapeutics Com New (JSPR)
Zevra Therapeutics Com New (ZVRA)
Miragen Therapeutics (VRDN)

View all positions for Propel Bio Management

Top funds holding Miragen Therapeutics

FMR
BlackRock
Deep Track Capital
Kynam Capital Management
Vanguard Group
VR Adviser
Fairmount Funds Management
Commodore Capital
Tang Capital Management
Paradigm Biocapital Advisors
State Street Corporation
Novo A/S
Maverick Capital
Eversept Partners
Alliancebernstein

View all funds holding Miragen Therapeutics